氧化chloroquine 改变了脂蛋白颗粒的度和组成
Thiago B Mendes1, Rachel G Miller2, Frederico G S Toledo1
1Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA (Mendes and Toledo).
Journal of clinical lipidology
|February 18, 2026
概括
氧化 (HCQ) 通过降低LDL粒子度和VLDL甘油三含量,显著降低总胆固醇和甘油三. 它还改变了HDL颗粒的分布,表明了潜在的心血管益处.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 脂质代谢 脂质代谢是什么
背景情况:
- 氧化 (HCQ) 是一种用于自身免疫性疾病的免疫调节药物.
- 观察性研究表明,HCQ可能会降低胆固醇和甘油三水平,这意味着对心血管有好处.
- 缺乏由HCQ诱导的脂蛋白颗粒变化的详细表征.
研究的目的:
- 评估HCQ对循环脂质的影响.
- 评估脂蛋白度和组成的变化.
- 阐明HCQ脂质调节作用背后的机制.
主要方法:
- 一个随机,安慰剂控制,双盲试验的后期分析.
- 参与者是2型糖尿病风险较大的成年人.
- 从基线对安慰剂调整的变化被分析使用混合效应模型,控制共变量.
主要成果:
- 它降低了总胆固醇 (10.4%),LDL胆固醇 (12.9%) 和非HDL胆固醇 (15.0%).
- LDL颗粒度下降了15.1%,ApoB则下降了9.7%.
- 三甘油下降了27.8%,每颗VLDL颗粒的三甘油含量减少;高脂组成转向更大的颗粒.
结论:
- 在脂蛋白类别中,HCQ显著改变脂蛋白度和组成.
- 该药物通过降低LDL粒子度来降低总胆固醇.
- 通过降低VLDL甘油三含量,HCQ降低了甘油三含量,并改变了HDL大小分布,这表明了潜在的甲状腺保护作用.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Hepatic Drug Clearance: Effect of Protein Binding
591
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
591
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
259
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
259
Factors Affecting Drug Distribution: Miscellaneous Factors
1.1K
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
1.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
656
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
656


